Francis deSouza, Illumina CEO (Photographer: Stefan Wermuth/Bloomberg via Getty Images)
April 3, 2023 10:49 AM EDT
R&D

FTC or­ders Il­lu­mi­na to di­vest Grail, adding pres­sure amid ac­tivist fight with Ic­ahn

Jared Whitlock

Features Editor

The Fed­er­al Trade Com­mis­sion has or­dered Il­lu­mi­na to di­vest Grail, re­vers­ing an ad­min­is­tra­tive law judge’s rul­ing and adding more pres­sure for Il­lu­mi­na to un­wind …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times